The Cyclooxygenase 2 Inhibitor Market was valued at USD 16.06 billion in 2025 and is projected to reach USD 26.08 billion by 2033, growing at a CAGR of 6.25% from 2026 to 2033. The Cyclooxygenase-2 (COX-2) Inhibitor market is experiencing steady growth driven by the rising prevalence of chronic pain disorders, osteoarthritis, rheumatoid arthritis, and postoperative inflammation, along with increasing demand for safer and more targeted anti-inflammatory therapies. Growing clinical preference for selective COX-2 inhibitors over traditional NSAIDs is further supporting market expansion due to their improved gastrointestinal safety profile and reduced risk of ulcers and bleeding complications.
2 Views